COVID-19

COVID-19, also known as Covid or corona, is the disease caused by the coronavirus SARS-CoV-2. It is still present in the Netherlands. Information about the virus, the COVID-19 vaccinations and the latest figures is available on these pages.

COVID-19 is the disease caused by the coronavirus SARS-CoV-2. Read more about the virus, the disease, and its symptoms.

COVID-19 vaccination

If you have a higher risk of serious illness due to COVID-19, you can get vaccinated. Read about COVID-19 vaccination and who is eligible.

Professionals

Detailed information about implementation of the COVID-19 vaccinations is available for professionals. (More details in Dutch.)

Facts and figures

RIVM will continue monitoring the spread of the SARS-CoV-2 virus. Read more about the current COVID-19 figures.

Research

An overview of all the ongoing and concluded research at RIVM related to COVID-19 and the coronavirus SARS-CoV-2.

Privacy

Information on why vaccination data is registered and how your privacy is ensured.

News about COVID-19 and vaccination

New research portal for people with post-COVID

Starting today, people with post-COVID can sign up to take part in scientific research. They can register through the national portal at postcovidonderzoek.nl, which is part of the Post-COVID Network Netherlands.

Well-being should be considered from the start when formulating policy during pandemic, health emergency or other crisis

Monitoring well-being from the outset and throughout the duration of a pandemic, health emergency or other crisis provides helpful input in making policy choices.

Study on the effectiveness of COVID-19 measures in the Netherlands

The measures implemented in the Netherlands during the COVID-19 crisis were effective against the spread of the SARS-CoV-2 virus. This is the outcome of a study conducted by RIVM.

Air pollution increases risk of infection and severity of illness from COVID-19

People who live in areas with poor air quality are more likely to become infected with SARS-CoV-2. Moreover, the symptoms of COVID-19 are more severe, leading to more hospitalisations and deaths. This is the outcome of a study conducted by RIVM, Utrecht University, Wageningen University & Research and the Netherlands Municipal Public Health Services and Medical Assistance in Accidents and Disasters.

More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round

In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.

Booster vaccinations reduced risk of death from COVID-19 in 2022

Booster vaccinations reduced the risk of dying from COVID-19 in 2022. The risk of death from other causes was also lower for people who had a booster jab than for people without a booster jab. These findings are from research by RIVM.

More news

FAQ about COVID-19 and the coronavirus SARS-CoV-2

My question about COVID-19; an initiative of the Ministry of Health, Welfare and Sport (VWS), in partnership with RIVM and the umbrella organisation of the Municipal Public Health Services (GGD-GHOR)

Other coronaviruses

Coronaviruses mostly affect the respiratory system (nose, mouth and airways).
Besides SARS-CoV-2, other examples of coronaviruses are Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV1).